Researchers examining chloroquine (CQ), an antimalarial medication often suggested as a potential treatment for COVID-19, ended their study early over fears that patients were at an increased risk of significant heart complications.

Is the new coronavirus keeping patients from seeking medical attention?

The ongoing COVID-19 pandemic has resulted in massive changes for healthcare providers all over the world. A new survey explores that impact on cardiology in great detail. 

One cardiologist is sharing his own experience with the new coronavirus to try and help others understand it can be beaten. 

The American Medical Association (AMA) has published two new documents designed to help physicians affected by the ongoing COVID-19 pandemic.

U.S. hospitals are facing numerous challenges as they work to combat the continued spread of COVID-19, according to a new government survey of more than 300 hospital administrators.

Healthcare providers should use caution when considering the treatment of COVID-19 patients with hydroxychloroquine and azithromycin if the patients have cardiovascular disease.

As COVID-19 continues to keep healthcare providers busy, fewer patients appear to be seeking care for other serious issues, including cardiovascular complications such as heart attack and stroke.

In a Journal of Urgent Care Medicine analysis, experts reported that 89% of those confirmed to have the disease displayed normal or mildly abnormal CXRs.